Dockets

Request that FDA remove the Mifepristone Shared System REMS Program, including but not limited to the three ETASU requiring prescriber certification, pharmacy certification, and a patient agreement form

Request that the FDA remove the Mifepristone REMS Program, including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form

Requests that absent new peer-reviewed studies or otherwise robust scientific or clinical evidence warranting such action, FDA take no action that would reduce patient access to mifepristone and/or increase the burdens associated with prescribing or dispensing mifepristone.

Adam Kleinschmit - Exemption/Rulemaking

Food and Drug Administration’s Foods Program Guidance Agenda

Requests that the FDA Limit the Exposure of Refined Carbohydrates used in Industrial Processing in order to Prevent Obesity, Diabetes, and Cardiovascular Disease in Children and Adults

Request that the FDA implement urgent and decisive measures to protect animal and public health in light of mounting evidence regarding the risks associated with Zorbium (buprenorphine, NADA 141547, Schedule III opioid)

Request for Comments on Barriers and Solutions for Submitting Data to the Fatality Analysis and Reporting System Pursuant to Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities

Revitalizing Washington Dulles International Airport

Tactical Electronics and Military Supply LLC - Exemption/Rulemaking

Requests that the FDA order and/or take an administrative action, as provided in the below proposed order; under the Authority: 5 U.S.C. §551-§558, §701-§706; 15 U.S.C. §1451-§1461; 21 U.S.C. §141-§149, §321-§397, §467f, §679, §821, §1034; 28 U.S.C. §2112; 42 U.S.C. §201, §262, §263b, §264.

Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards